Hypertrophic Cardiomyopathy: Clinical Trials

160 trials for Hypertrophic Cardiomyopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

73 completed, 40 unknown, 21 recruiting, 8 active not recruiting. 32 Not applicable, 25 Phase 2, 10 Phase 3, 8 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable32Completed 13, Unknown 8, Terminated 3, Active not recruiting 2, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Phase 225Completed 17, Unknown 3, Recruiting 2, Terminated 2, Active not recruiting 1
Phase 310Completed 5, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 18Completed 5, Unknown 2, Recruiting 1
Phase 46Completed 3, Unknown 2, Terminated 1
Early Phase 11Completed 1

Follow Hypertrophic Cardiomyopathy: new trials by email Literature Review of Hypertrophic Cardiomyopathy trials Research Report on Hypertrophic Cardiomyopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
SESAME Procedure - Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
Not applicableNot yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)2002026-11-022026-10-28
Echocardiographic Perspectives on Transient Mitral Regurgitation After Septal Myectomy
Hypertrophic Cardiomyopathy
Not yet recruitingUniversity Health Network, Toronto1502026-10-012026-10-14
Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy
Coronary sinus reducer, Placebo procedure - Hypertrophic Cardiomyopathy
Not applicableNot yet recruitingImperial College London502026-10-012026-10-08
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Mavacamten - Hypertrophic Cardiomyopathy
RecruitingBristol-Myers Squibb5002026-01-152026-06-18
Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy
myPACE+ algorithm - Non-obstructive Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy
Not applicableTerminatedMontefiore Medical Center12025-10-022026-02-11
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
HRS-1893 Tablet - Hypertrophic Cardiomyopathy
Phase 2RecruitingShandong Suncadia Medicine Co., Ltd.3002025-07-042025-09-10
A Trial of HRS-1893 in Healthy Volunteers
HRS-1893 - Hypertrophic Cardiomyopathy
Early Phase 1CompletedAtridia Pty Ltd.202025-06-252025-11-18
VIZ ACCESS HCM - Multi-Site Registry
Viz HCM - Hypertrophic Cardiomyopathy
TerminatedViz.ai, Inc.172025-06-132026-09-23
Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring
ATP-C135, ATP-C75 - Hypertrophic Cardiomyopathy
Phase 3Not yet recruitingYonsei University1002025-03-012025-03-13
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function
HRS-1893 - Hypertrophic Cardiomyopathy
Phase 1CompletedShandong Suncadia Medicine Co., Ltd.242025-02-112025-09-10
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study
Septal Scoring Along Midline Endocardium - Hypertrophic Cardiomyopathy, Left Ventricular Septal Hypertrophy
Not applicableTerminatedNational Heart, Lung, and Blood Institute (NHLBI)12024-12-182025-12-18
Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients
Inspiratory Muscle Training, Baduanjin Exercise - Hypertrophic Cardiomyopathy, Heart Diseases
Not applicableRecruitingIstanbul University - Cerrahpasa512024-10-252025-06-15
Institutional Registry of Rare Diseases
Rare Diseases, Amyloidosis
RecruitingHospital Italiano de Buenos Aires3802024-07-012026-01-14
Hypertrophic Cardiomyopathy Federated Learning Implementation Platform
Hypertrophic Cardiomyopathy
UnknownAmerican Heart Association10002024-06-052024-08-06
A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's
12-Lead ECG, Apple Smart Watch Single Lead ECG, AliveCor KardiaMobile 6-Lead ECG - Hypertrophic Cardiomyopathy
Active not recruitingMayo Clinic1832024-05-072026-03-19
Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy, Obstructive
UnknownAmsterdam UMC, location VUmc1002024-05-012024-05-06
A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada
Mavacamten - Hypertrophic Cardiomyopathy
CompletedBristol-Myers Squibb6832024-04-202026-06-12
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
EDG-7500 - Hypertrophic Cardiomyopathy
Phase 2Active not recruitingEdgewise Therapeutics, Inc.792024-04-112026-07-31
Echocardiography-guided Percutaneous Septal Radiofrequency Ablation for Obstructive HCM After Alcohol Septal Ablation
Percutaneous Intramyocardial Septal Radiofrequency Ablation - Hypertrophic Cardiomyopathy
UnknownXijing Hospital122024-03-262024-07-11
Austrian Hypertrophic Cardiomyopathy Registry
Hypertrophic Cardiomyopathy
RecruitingMedical University of Graz10002024-03-082025-12-05

Showing 20 of 160. Sign in to see all of them.

Narrower conditions

Cardiomyopathy, Hypertrophic (160)  ·  Cardiomyopathy, Dilated (16)  ·  Cardiomyopathies (11)  ·  Heart Failure (11)  ·  Arrhythmogenic Right Ventricular Dysplasia (8)  ·  Cardiomyopathy, Restrictive (8)  ·  Coronary Artery Disease (7)  ·  Hypertrophy (7)  ·  Arrhythmias, Cardiac (6)  ·  Hypertrophy, Left Ventricular (6)  ·  Atrial Fibrillation (5)  ·  Death, Sudden, Cardiac (5)  ·  Heart Diseases (5)  ·  Cardiomyopathy, Hypertrophic, Familial (4)  ·  Cardiovascular Diseases (4)

Broader conditions

Aortic Stenosis, Subvalvular (160)  ·  Aortic Valve Disease (159)  ·  Heart Valve Diseases (159)  ·  Aortic Valve Stenosis (157)  ·  Cardiovascular Diseases (156)  ·  Heart Diseases (155)  ·  Cardiomyopathies (149)  ·  Pathological Conditions, Signs and Symptoms (40)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (30)  ·  Genetic Diseases, Inborn (25)  ·  Pathologic Processes (24)  ·  Cardiomegaly (21)  ·  Laminopathies (16)  ·  Vascular Diseases (16)  ·  Cardiovascular Abnormalities (15)

Interventions

MYK-461 (7)  ·  Echocardiography (3)  ·  Exercise (3)  ·  Losartan (3)  ·  Perhexiline (3)  ·  Blood Specimen Collection (2)  ·  Electrocardiography (2)  ·  Electrocardiography, Ambulatory (2)  ·  Ethanol (2)  ·  Metoprolol (2)  ·  Spironolactone (2)  ·  empagliflozin (2)  ·  sacubitril and valsartan sodium hydrate drug combination (2)  ·  Acetylcysteine (1)  ·  Adenosine (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (13)  ·  Bristol-Myers Squibb (6)  ·  Mayo Clinic (6)  ·  Imperial College London (4)  ·  Barts & The London NHS Trust (3)  ·  The Cleveland Clinic (3)  ·  University Hospital Birmingham (3)  ·  University Hospital, Bordeaux (3)  ·  University Hospital, Montpellier (3)  ·  Xijing Hospital (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Beijing Institute of Heart, Lung and Blood Vessel Diseases (2)  ·  Brigham and Women's Hospital (2)  ·  Duke University (2)  ·  Far Eastern Memorial Hospital (2)

Countries

United States (56)  ·  United Kingdom (22)  ·  France (17)  ·  China (16)  ·  Canada (13)  ·  Germany (8)  ·  Italy (7)  ·  Netherlands (6)  ·  Australia (4)  ·  Denmark (4)  ·  Poland (4)  ·  Czechia (3)  ·  Israel (3)  ·  Spain (3)  ·  Sweden (3)

Top investigators

Jeffrey Geske, MD (2)  ·  Milind Desai, MD (2)  ·  Robert J Lederman, M.D. (2)  ·  Steven E Lipshultz, MD (2)  ·  Adolfo Fontenla, MD, PhD (1)  ·  Adrian Gadano, MD (1)  ·  Ali J. Marian, MD (1)  ·  Anne-Sophie Polge, PH (1)  ·  Benjamin D Levine, MD (1)  ·  Bo Wang, Master (1)  ·  Carolyn Y Ho, MD (1)  ·  Carolyn Y. Ho, MD (1)

Results publications

PMID 24621999, PMID 25533774, PMID 28912187, PMID 12957437, PMID 17572266, PMID 17582361, PMID 18164940, PMID 18403758, PMID 19074594, PMID 20837938, PMID 20921440, PMID 22075468, PMID 22932717, PMID 24361242, PMID 24414062, PMID 24674997, PMID 25176015, PMID 25387993, PMID 25533966, PMID 26299218, PMID 26661322, PMID 26680013, PMID 26874390, PMID 26898633, PMID 27059467, PMID 27247331, PMID 27265676, PMID 27326027, PMID 27437054, PMID 27590665, PMID 28306757, PMID 28400935, PMID 28547861, PMID 28662936, PMID 28682471, PMID 28917683, PMID 29018006, PMID 29161295, PMID 29249422, PMID 29321131, PMID 29540445, PMID 29604289, PMID 29754651, PMID 29797054, PMID 30018776, PMID 30316646, PMID 30725091, PMID 31333075, PMID 3160067, PMID 31745384

NIH funding

1RC1LM010526 (1), K23HL078901 (1), P50HL112349 (1), R01HL111459 (1), R01HL125918 (1), R01HL134885 (1), R01HL157238 (1), U01HL117006 (1)